The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth
Open Access
- 22 May 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 9 (6), 1-14
- https://doi.org/10.1038/s41419-018-0580-3
Abstract
Accumulating evidence suggests that placenta-specific 8 (PLAC8) plays an important role in normal cellular process and human diseases, including multiple types of human tumors, and its role is highly relied upon in cellular and physiologic contexts. However, there are no reports on its expression profile and biological roles during lung cancer development. In the current study, both the clinical implications and biological effects of PLAC8 in lung cancer (LC) progression were investigated, and we identified and described the novel Krüppel-like factor 4 (KLF4)/PLAC8 regulatory pathway in cancer progression. Elevated PLAC8 levels were positively correlated with tumor size, histological grade, and tumor node metasis (TNM) stage, and LC patients with high PLAC8 expression suffered poor outcomes. In vitro and in vivo assays further revealed that endogenous PLAC8 promoted cell proliferation and tumor formation. We also found downregulated PLAC8 protein in several LC cell lines following the induction of KLF4, and immunohistochemistry analysis of LC tissues by microarray indicated a potential inverse correlation between PLAC8 and KLF4 expression. Luciferase reporter analysis and chromatin immunoprecipitation assays determined that KLF4 negatively regulated PLAC8 promoter activity via directly binding to the promoter region. Furthermore, the growth inhibition resulting from KLF4 overexpression was partially rescued by ectopic PLAC8 expression. Together, our data uncovered a previously unidentified role of PLAC8 as a central mediator in LC progression. PLAC8 was transcriptionally repressed by KLF4, and the novel KLF4/PLAC8 axis may act as a promising candidate target for LC diagnosis and therapy.This publication has 58 references indexed in Scilit:
- Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug ExpressionPLOS ONE, 2012
- Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone ResorptionPLOS ONE, 2012
- KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal CarcinomaThe American Journal of Pathology, 2011
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasionOncogene, 2011
- Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung CarcinomaClinical Cancer Research, 2009
- Krüppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipidsAmerican Journal of Physiology-Cell Physiology, 2008
- Synergistic response to oncogenic mutations defines gene class critical to cancer phenotypeNature, 2008
- A core Klf circuitry regulates self-renewal of embryonic stem cellsNature, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiationThe EMBO Journal, 2007